Periodic Reporting for period 2 - TAONas-LUAD (Therapeutic Antisense Oligonucleotides Targeting NUMB Alternative Splicing in Lung Adenocarcinoma)

Lung cancer remains the leading cause of cancer-related mortality worldwide, with non-small cell lung cancer (NSCLC) accounting for most of the cases. Within NSCLC, lung adenocarcinomas (LUAD) represent 1/3 of all lung cancer cases. Despite advances in research and clinical...